 
 
 
 
 
 
 
 
 
INTRODUCTION
Telomeres consist of long (TTAGGG)n nucleotide
repeats and an ordered protein complex at the ends of
chromosomes that are essential to maintaining
chromosomal integrity [1]. Telomere length (TL)
shortens with each cell division and thus is an important
marker of aging. It is also associated with the risk of
several degenerative and age related diseases, including
cancer [2,3]. Individuals with dyskeratosis congenita
(DC), a cancer susceptibility and inherited bone marrow
failure syndrome (IBMFS), have mutations in genes
important in telomere biology, including DKC1, TERC,
TERT, TINF2, NHP2 and NOP10 [4]. They also have
very short telomeres for age compared with unaffected
family members or age-matched controls [5]. Typically,
DC is clinically defined by the triad of lacy, reticular
skin pigmentation, nail dystrophy, and oral leukoplakia.
Patients are at very high risk of bone marrow failure,
Research Paper
cancer, pulmonary fibrosis, and other medical
complications [4,6]. The presence of very short
telomeres in leukocyte subsets as measured by auto-
mated multicolor fluorescence in situ hybridization
combined with flow-cytometry (flow-FISH) [7] , is a
useful tool for differentiating patients with DC from
healthy individuals [8,9].
TL abnormalities have been reported in a few patients
with other IBMFS, including Fanconi anemia (FA)
[10,11], Shwachman Diamond syndrome (SDS) [12],
and, to a lesser extent, in Diamond Blackfan anemia
(DBA) [13], but the degree of telomere shortening
is usually not as profound as in DC. When compared
with DC, the short telomeres in patients with non-DC
IBMFS are mainly observed in granulocytes [8],
suggesting the presence of rapid granulocyte stem/
progenitor cell turnover in response to bone marrow
stress.
Telomere length in blood, buccal cells, and fibroblasts from patients
with inherited bone marrow failure syndromes
  
Shahinaz M. Gadalla1,2
, Richard Cawthon3
, Neelam Giri1
, Blanche P. Alter1
, Sharon A. Savage1
 
 
1
Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National 
Institutes of Health, Rockville, MD 20852, USA 
2
Cancer Prevention Fellowship Program, National Cancer Institute, Rockville, MD 20852, USA 
3
Department of Human Genetics, University of Utah, 15 N 2030 E, Room 2100, Salt Lake City, UT 84112, USA 
 
Key words: telomere, correlation, dyskeratosis congenita, bone marrow failure 
Corresponding author: Sharon A. Savage, MD;      E‐mail:  savagesh@mail.nih.gov
Received: 10/14/10; Accepted: 11/21/10; Published: 11/23/10 
Copyright: © Gadalla  et al. This is an open‐access article distributed under the terms of the Creative Commons Attribution License, which 
permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited 
 
Abstract:  Telomeres,  the  nucleotide  repeats  and  protein  complex  at  chromosome  ends,  are  required  for  chromosomal
stability and are important markers of aging.  Patients with dyskeratosis congenita (DC), an inherited bone marrow failure
syndrome  (IBMFS),  have  mutations  in  telomere  biology  genes,  and  very  short  telomeres.  There  are  limited  data  on
intra‐individual telomere length (TL) variability in DC and related disorders. We measured relative TL by quantitative‐PCR in
blood, buccal cells, and fibroblasts from 21 patients with an IBMFS (5 Diamond‐Blackfan anemia, 6 DC, 6 Fanconi anemia,
and 4 Shwachman‐Diamond syndrome). As expected, TL in patients with DC was significantly (p<0.01) shorter in all tissues
compared with other IBMFS. In all disorders combined, the median Q‐PCR TL was longer in fibroblast and buccal cells than
in  blood  (overall  T/S  ratio=1.42  and  1.16  vs.  1.05,  p=0.001,  0.006,  respectively).  Although  the  absolute  values  varied,
statistically  significant  intra‐individual  correlations  in  TL  were  present  in  IBMFS  patients:  blood  and  fibroblast
(r=0.66, p=0.002), blood and buccal cells (r=0.74, p<0.0001), and fibroblast and buccal cells (r=0.65, p=0.004). These data
suggest that relative TL is tissue‐ independent in DC and possibly in the other IBMFS.      
 
 
www.impactaging.com                   867                                  AGING,  November 2010, Vol.2 No.11
Data on the comparability between tissue TL, and
correlations between TL measured in different tissues
from the same individual are limited. Some studies,
mostly in the elderly, suggest a possible variability
in TL across tissues [14-17]. Studies of telomere
length in cancer and other diseases have only
evaluated either the abnormal tissue [18-20],
peripheral blood [21-23], or buccal cells [24,25]. In
one study, the average TL in five different tissue types,
cerebral cortex, myocardium, liver, renal cortex and
liver, was found to correlate within an individual [26].
Studies of TL in DC patients also showed short
telomeres in cultured skin fibroblasts [27] and
keratinocytes [28].
In order to better understand intra-individual TL
variation in IBMFS, we compared TL, measured by Q-
PCR, in DNA extracted from blood, buccal cells, and
cultured fibroblasts within and between the four major
IBMFS disorders, DC, FA, SDS, and DBA. We also
assessed TL intra-individual correlations between
tissues overall and within disorders.
 
 
       Table 1. Demographic and Clinical Characteristics of Study participants 
Combined
IBMFS
N=21
By Disorder
DC
N=6
FA
N=6
DBA
N=5
SDS
N=4
N (%)
Age at sample drawing (yrs)
Median (range)^ 21 (8-43) 16 (10-31) 27 (16-33) 30 (8-43) 12.5 (11-
42)
Gender
Male
Female
15
(71.4%)
6 (28.6%)
6 (100%)
0
3 (50%)
3 (50%)
4 (80%)
1 (20%)
2 (50%)
2 (50%)
Aplastic Anemia
None
Moderate
Severe
9 (43%)
7 (33%)
5 (24%)
1
4
1
4
0
2
3
0
2*
1
3
0
^ The majority of samples for patients with IBMFS were collected on the same clinic day. The maximum time interval between 
sample collections in an individual patient was 1.8 years. 
* Two patients with DBA had severe anemia requiring red blood cell transfusions for one patient, and prednisone in the other. 
Their white blood count and platelet counts were not affected. 
Abbreviations:  IBMFS,  inherited  bone  marrow  failure  syndromes;  DC,  dyskeratosis  congenita;  FA,  Fanconi  Anemia;  DBA, 
Diamond Blackfan Anemia; SDS, Shwachman Diamond Syndrome; N, number; Kb, kilobases 
 
 
www.impactaging.com                   868                                 AGING, November 2010, Vol.2 No.11
RESULTS
Table 1 summarizes the characteristics of the study
participants. The ages of the patients ranged from 8 to
43 years (median=21), most were males (71.4%), and
about one-fourth had severe aplastic anemia. As
expected, telomeres were significantly shorter in
patients with DC than in patients with other IBMFS in
blood (median T/S, or relative TL=0.61 vs. 1.13,
p=0.001), buccal cells (0.80 vs. 1.25, p=0.009), and
fibroblasts (0.84 vs. 1.56, p=0.001) (Figure 1). In all
IBMFS patients combined, median TL was longer in
fibroblasts and buccal cells when compared with blood
(1.42 and 1.16 vs. 1.05, p=0.001, 0.006, respectively)
(Figure1). The same pattern was observed across each
specific IBMFS (Table 2)
When evaluating the intra-individual correlations be-
tween TL measurements in blood, buccal and fibroblast
trios in all IBMFS patients, we observed significant
correlations between blood and fibroblasts (r=0.66,
p=0.002), blood and buccal cells (r=0.74, p<0.0001),
and fibroblasts and buccal cells (r=0.65, p=0.004)
measurements. Disease-specific analyses showed that
this correlation was primarily derived from the
strong correlation between TL in blood and buccal
(r=0.90, p=0.04), buccal and fibroblast (r=0.90, p=0.04)
in patients with DC, and TL in blood and fibroblast
(r=1.0, p<0.0001) in patients with SDS. Likewise,
we observed a positive, however not statistically
significant, correlation between TL in buccal cells
and blood in patients with FA (r=0.60, p=0.28) and
DBA (r=0.70, p=0.19). A positive non-significant
correlation was also observed between fibroblast and
buccal TL in patients with DBA (r=0.70, p=0.19).
Surprisingly, a strong negative correlation was present
between fibroblast and buccal TL (r=-1.0, p<0.0001)
in patients with FA (Table 3).
 
 
www.impactaging.com                   869                                  AGING, November 2010, Vol.2 No.11
Figure 1. Comparison of Q‐PCR blood, fibroblast and buccal cell DNA telomere length (TL) in DC patients,
and patients with other IBMFS combined. Q‐PCR TL (on the Y axis) is measured as a ratio of telomere copy
number  (T)  to  single  copy  gene  (S)  (T/S);  p‐values  represent  the  global  difference  in  tissues  TL  and
obtained from Friedman test. Abbreviations: IBMFS, inherited bone marrow failure syndromes. 
Table 2. Blood, buccal cells, and fibroblast Q‐PCR telomere length in all 
participants combined and by disorder 
Tissue type Number Median TL Range p-value*
All patients with IBMFS
Blood 21 1.05 0.40-1.86 Reference
Buccal cells 19 1.16 0.51-6.44 0.006
Fibroblasts 20 1.42 0.47-2.20 0.001
Dyskeratosis Congenita
Blood 6 0.61 0.40-0.99 Reference
Buccal cells 5 0.80 0.51-1.16 0.04
Fibroblasts 6 0.84 0.47-1.16 0.17
Fanconi Anemia
Blood 6 1.13 0.79-1.35 Reference
Buccal cells 5 1.22 0.96-1.46 0.70
Fibroblasts 5 1.73 1.39-2.20 0.04
Diamond-Blackfan Anemia
Blood 5 1.13 0.99-1.86 Reference
Buccal cells 5 1.52 1.03-2.23 0.08
Fibroblasts 5 1.60 1.15-1.69 0.14
Shwachman-Diamond Syndrome
Blood 4 1.18 0.99-1.54 Reference
Buccal cells 3 1.39 1.04-6.44 0.11
Fibroblasts 4 1.48 1.18-2.17 0.07
*Wilcoxon signed rank test for paired samples 
Abbreviations: TL, telomere length; IBMFS, inherited bone marrow failure syndromes
 
 
www.impactaging.com                   870                                  AGING,  November 2010, Vol.2 No.11
 
DISCUSSION
Proper telomere length and structure are critical for
chromosomal stability. Telomeres shorten with each
cell division and are also susceptible to oxidative stress.
TL is an important marker for aging, and appears to be
associated with risk of several diseases, including
cancer. Telomere biology disorders encompass a broad
clinical spectrum, ranging from dyskeratosis congenita
with its diagnostic triad and young age of onset, to
isolated aplastic anemia or pulmonary fibrosis
diagnosed later in life [29]. Telomeres have been
reported to be shorter than normal in some patients with
FA, SDS, and DBA, but in these cases they are not as
abnormally short as in DC. In this study, we sought to
understand the variability in telomere length within and
between different tissues derived from patients with
these IBMFS.
In all IBMFS patients combined, TL in DNA samples
extracted from blood was significantly shorter than that
extracted from fibroblasts or buccal cells; a pattern that
was observed across disorders, but did not reach
statistical significance in some of them. More than half
(57%) of our patients had moderate to severe aplastic
anemia and the remainder are at high risk of its
development. It is possible that the shorter telomeres in
patients’ blood cells could be a result of higher telo-
mere attrition due to the relatively rapid turnover of
hematopoietic cells in response to bone marrow stress.
Table  3.  Correlation  coefficients  (r)  between  telomere  lengths 
measured by Q‐PCR in blood, buccal cells and fibroblasts DNA. 
 
Tissue type
Blood Fibroblast Buccal cells
N r^
N r^
N r^
All patients with IBMFS
Blood 21 1.00 20 0.66** 19 0.74**
Fibroblast 20 0.67** 20 1.00 18 0.65**
Dyskeratosis Congenita
Blood 6 1.00 6 0.45 5 0.90*
Fibroblast 6 0.43 6 1.00 5 0.90*
Fanconi anemia
Blood 6 1.00 5 -0.10 5 0.60
Fibroblast 5 -0.10 5 1.00 4 -1.00**
Diamond-Blackfan Anemia
Blood 5 1.00 5 0.30 5 0.70
Fibroblast 5 0.30 5 1.00 5 0.70
Shwachman-Diamond Syndrome
Blood 4 1.00 4 1.00** 4 0.50
Fibroblast 4 1.00** 4 1.00 4 0.50
 
^ Spearman rank correlation coefficient; *p≤0.05; ** p≤0.01 
Abbreviations: IBMFS, inherited bone marrow failure syndromes 
 
 
www.impactaging.com                   871                                  AGING, November 2010, Vol.2 No.11
In DC, it is also due to their underlying defect in
telomere biology. Our finding of longer telomeres in
fibroblasts than in blood cells is in agreement with
another report of TL in healthy centenarians and
controls of different ages [16]. In support of this
observation, a higher annual rate of telomere attrition
has been reported in leukocytes (approximately
30bp/year) [16;30;31] than in fibroblasts (15bp/year)
[32]. When comparing blood and buccal telomere
length, our finding was discordant with the reported
longer telomeres in leukocytes compared with buccal
cells in patients with Alzheimer disease and their age-
matched controls [17]; this difference could be due to
differences in disease biology, different DNA extraction
methods and/or limitations in sample size.
Although the absolute TL values varied between blood,
buccal cells, and fibroblast DNA, we observed strong
intra-individual correlations between the three tissues;
buccal cells showed consistent correlation across
IBMFS; however, this correlation did not reach
statistical significance when the disorders were
evaluated individually. This finding is in contrast to the
observed lack of correlation between blood and buccal
TL in healthy individuals and patients with Alzheimer’s
disease reported by another study [17]. Surprisingly, we
observed an inverse correlation between buccal cell and
fibroblast TL in patients with FA. This could
theoretically be related to the high oral cancer
susceptibility in FA patients. Of the 5 patients with FA
included in this study, one had oral cancer 3 years prior
to as well as 2 years after sample collection; a second
patient with FA had oral cancer 5 years after sample
collection. Larger sample sizes are required to better
understand these findings. Our observed strong
correlation between blood and fibroblast TL in patients
with SDS is an interesting finding that needs further
evaluation.
TL correlations in different tissues have been observed
in several other studies. Specifically, between
fibroblasts and leukocytes (r2
=0.80, p=0.0006)[15],
bone marrow and skin (r2
= 0.77), vocal fold and blood
(r2
= 0.84), skin and vocal folds (r2
=0.62)[33],
epidermal and lingual epithelium (r=0.84, p<0.0001)
[34], and each pair of the following tissues: cerebral
cortex, myocardium, liver, and renal cortex [26]. In our
study, we observed a strong correlation profile between
evaluated DNA samples in patients with DC, where
heritable telomere dysfunction is present, particularly
between blood and buccal cells (r=0.90) and buccal
cells and fibroblasts (r=0.90). This suggests that short
telomeres in DC are not limited to blood or fibroblasts,
observations that have been previously reported [27],
but are also present in buccal cells. This finding also
suggests that the heritability of telomere length in DC is
tissue independent.
In conclusion, overall Q-PCR TL in patients with
IBMFS was correlated between blood, buccal cells and
fibroblasts, but there was some variability within
different IBMFS. This small pilot study suggests that
blood or tissue Q-PCR TL could theoretically be useful
as a first screen for individuals with a suspected
telomere biology disorder. However, much larger
studies are needed to evaluate the reliability and validity
of this test in comparison to the standard diagnostic
method of flow-FISH.
METHODS
Ethical statement. This investigation was conducted in
accordance with the ethical standards and according to
the Declaration of Helsinki and the national and
international guidelines and has been approved by the
National Cancer Institute’s (NCI) institutional review
board.
Study participants. The study included 21 patients with
IBMFS; 5 Diamond Blackfan anemia (DBA), 6
Dyskeratosis Congenita (DC), 6 Fanconi anemia (FA),
and 4 Shwachman-Diamond syndrome (SDS) who were
enrolled in the NCI study entitled “Etiologic
Investigation of Cancer Susceptibility in Inherited Bone
Marrow Failure Syndromes” and provided blood,
buccal cells, and fibroblast samples. Study details are
available elsewhere [35]. Briefly, evaluation of patients
described in this cohort includes systematic review of
medical records, careful physical examination, complete
blood counts, bone marrow studies, skin biopsy, buccal
cell collection, and other appropriate diagnostic tests.
DNA extraction and telomere length measurements.
Genomic DNA from blood cells was extracted from
either whole blood (4 samples; 3 DBA and 1 DC) or the
white blood cell pellet remaining after density gradient
separation (17 samples, primarily granulocytes) by
manual Gentra Puregene procedure (Qiagen Inc.,
Valencia, CA). Skin fibroblasts were cultured from
punch biopsies and stored at -80˚C. Buccal cells were
collected using Scope mouthwash. DNA was isolated
from fibroblasts and buccal cells by phenol-chloroform
extraction.
TL was measured using the Quantitative- Polymerase
Chain Reaction (Q-PCR) method previously described
[36]. Briefly, the relative TL was estimated from the
ratio of the telomere (T) repeat copy number to a single
gene (human β-globin gene) (S) copy number (T/S
ratio) for each sample using standard curves. For
 
 
www.impactaging.com                   872                                  AGING, November 2010, Vol.2 No.11
quality control, all Q-PCR TL measurements were done
in triplicates. The average coefficients of variation (CV)
between triplets for blood, buccal and fibroblast
samples were 6.4%, 7.3%, and 7.9%, respectively.
Statistical analysis. We used Wilcoxon signed-rank test
to compare the median ranks of TL within each disorder
(buccal, and fibroblast vs. blood), and Mann-Whitney
test to compare tissue-specific TL between DC and
other IBMFS. Spearman rank correlation coefficient (R)
was used to evaluate the intra-individual correlations
between Q-PCR TL in blood-fibroblast-buccal cell
trios. Analyses were done using SPSS.17 statistical
software.
ACKNOWLEDGEMENTS
We thank the patients and their families for their
generous participation in the study. We are grateful to
Lisa Leathwood, RN, Westat Inc., for outstanding
clinical support. This work was funded by the intra-
mural research program of the Division of Cancer
Epidemiology and Genetics (DCEG), National Cancer
Institute, National Institutes of Health.  
 
CONFLICT OF INTERESTS STATEMENT
The authors of this paper declare no conflict of interests.
REFERENCES
1. Rodier F, Kim SH, Nijjar T,  Yaswen P, Campisi J. Cancer and 
aging: the importance of telomeres in genome maintenance. Int 
J Biochem Cell Biol. 2005; 37: 977‐990. 
2.  Aviv  A.  The  epidemiology  of  human  telomeres:  faults  and 
promises. J Gerontol A Biol Sci Med Sci. 2008; 63: 979‐983. 
3. Aubert G and Lansdorp PM. Telomeres and aging. Physiol Rev. 
2008; 88: 557‐579. 
4.  Savage  SA  and  Alter  BP.  Dyskeratosis  congenita.  Hematol 
Oncol Clin North Am. 2009; 23: 215‐231. 
5.  Vulliamy  TJ,  Knight  SW,  Mason  PJ,  Dokal  I.  Very  short 
telomeres in the peripheral blood of patients with X‐linked and 
autosomal dyskeratosis congenita. Blood Cells Mol Dis. 2001; 27: 
353‐357. 
6. Kirwan M and Dokal I. Dyskeratosis congenita, stem cells and 
telomeres. Biochim Biophys Acta. 2009; 1792: 371‐379. 
7.  Baerlocher  GM,  Vulto  I,  de  Jong  G,  Lansdorp  PM.  Flow 
cytometry and FISH to measure the average length of telomeres 
(flow FISH). Nat Protoc. 2006; 1: 2365‐2376. 
8. Alter BP, Baerlocher GM, Savage SA, Chanock SJ, Weksler BB, 
Willner  JP  et  al.  Very  short  telomere  length  by  flow  fluore‐
scence in situ hybridization identifies patients  with  dyskeratosis 
congenita. Blood. 2007; 110: 1439‐1447. 
9. Du HY, Pumbo E, Ivanovich J, An P, Maziarz RT, Reiss UM et al. 
TERC  and  TERT  gene  mutations  in  patients  with  bone  marrow 
failure  and  the  significance  of  telomere  length  measurements. 
Blood. 2009; 113: 309‐316. 
10.  Ball  SE,  Gibson  FM,  Rizzo  S,  Tooze  JA,  Marsh  JC,  Gordon‐
Smith  EC.  Progressive  telomere  shortening  in  aplastic  anemia. 
Blood. 1998; 91: 3582‐3592. 
11. Li X, Leteurtre F, Rocha V, Guardiola P, Berger R, Daniel MT 
et  al.  Abnormal  telomere  metabolism  in  Fanconi's  anaemia 
correlates  with  genomic  instability  and  the  probability  of 
developing severe aplastic anaemia. Br J Haematol. 2003; 120: 
836‐845. 
12. Thornley I, Dror Y, Sung L, Wynn RF, Freedman MH. Abnormal 
telomere  shortening  in  leucocytes  of  children  with  Shwachman‐
Diamond syndrome. Br J Haematol. 2002; 117: 189‐192. 
13. Pavesi E, Avondo F, Aspesi A, Quarello P, Rocci A, Vimercati C 
et  al.  Analysis  of  telomeres  in  peripheral  blood  cells  from 
patients with bone marrow failure. Pediatr Blood Cancer. 2009; 
53: 411‐416. 
14. Butler MG, Tilburt J, DeVries A, Muralidhar B, Aue G, Hedges 
L  et  al.  Comparison  of  chromosome  telomere  integrity  in 
multiple  tissues  from  subjects  at  different  ages.  Cancer  Genet 
Cytogenet. 1998; 105: 138‐144. 
15.  Friedrich  U,  Griese  E,  Schwab  M,  Fritz  P,  Thon  K,  Klotz  U. 
Telomere  length  in  different  tissues  of  elderly  patients.  Mech 
Ageing Dev. 2000; 119: 89‐99. 
16. Mondello C, Petropoulou C, Monti D, Gonos ES, Franceschi C, 
Nuzzo  F.  Telomere  length  in  fibroblasts  and  blood  cells  from 
healthy centenarians. Exp Cell Res. 1999; 248: 234‐242. 
17.  Thomas  P,  O'  Callaghan  NJ,  Fenech  M.  Telomere  length  in 
white blood cells, buccal cells and brain tissue and its variation 
with  ageing  and  Alzheimer's  disease.  Mech  Ageing  Dev.  2008; 
129: 183‐190. 
18.  Meeker  AK,  Hicks  JL,  Iacobuzio‐Donahue  CA,  Montgomery 
EA,  Westra  WH,  Chan  TY  et  al.  Telomere  length  abnormalities 
occur  early  in  the  initiation  of  epithelial  carcinogenesis.  Clin 
Cancer Res. 2004; 10: 3317‐3326. 
19. Plentz RR, Caselitz M, Bleck JS, Gebel M, Flemming P, Kubicka 
S  et  al.  Hepatocellular  telomere  shortening  correlates  with 
chromosomal  instability  and  the  development  of  human 
hepatoma. Hepatology. 2004; 40: 80‐86. 
20. O'Sullivan JN, Bronner MP, Brentnall TA, Finley JC, Shen WT, 
Emerson S et al. Chromosomal instability in ulcerative colitis is 
related to telomere shortening. Nat Genet. 2002; 32: 280‐284. 
21.  Liu  X,  Bao  G,  Huo  T,  Wang  Z,  He  X,  Dong  G.  Constitutive 
telomere  length  and  gastric  cancer  risk:  case‐control  analysis     
in Chinese Han population. Cancer Sci. 2009; 100: 1300‐1305. 
22. Prescott J, McGrath M, Lee IM, Buring JE, De V, I. Telomere 
length  and  genetic  analyses  in  population‐based  studies  of 
endometrial cancer risk. Cancer. 2010; 116: 4275‐4282. 
23.  Mirabello  L,  Huang  WY,  Wong  JY,  Chatterjee  N,  Reding  D, 
Crawford ED et al. The association between leukocyte telomere 
length and cigarette smoking, dietary and physical variables, and 
risk of prostate cancer. Aging Cell. 2009; 8: 405‐413. 
24.  Broberg  K,  Bjork  J,  Paulsson  K,  Hoglund  M,  Albin  M. 
Constitutional  short  telomeres  are  strong  genetic  susceptibility 
markers for bladder cancer. Carcinogenesis. 2005; 26: 1263‐1271. 
25. Hewakapuge S, van Oorschot RA, Lewandowski P, Baindur‐
Hudson  S.  Investigation  of  telomere  lengths  measurement  by 
quantitative  real‐time  PCR  to  predict  age.  Leg  Med  (Tokyo). 
2008; 10: 236‐242. 
26. Takubo K, Izumiyama‐Shimomura N, Honma N, Sawabe M, 
Arai T, Kato M et al. Telomere lengths are characteristic in each 
human individual. Exp Gerontol. 2002; 37: 523‐531. 
 
 
www.impactaging.com                   873                                  AGING, November 2010, Vol.2 No.11
27. Westin ER, Chavez E, Lee KM, Gourronc FA, Riley S, Lansdorp 
PM  et  al.  Telomere  restoration  and  extension  of  proliferative 
lifespan in dyskeratosis congenita fibroblasts. Aging Cell. 2007; 
6: 383‐394. 
28.  Gourronc  FA,  Robertson  M,  Herrig  AK,  Lansdorp  PM, 
Goldman FD, Klingelhutz AJ. Proliferative defects in dyskeratosis 
congenita skin keratinocytes are corrected by expression of the 
telomerase  reverse  transcriptase,  TERT,  or  by  activation  of 
endogenous  telomerase  through  expression  of  papillomavirus 
E6/E7 or the telomerase RNA component, TERC. Exp Dermatol. 
2010; 19: 279‐288. 
29. Armanios M. Syndromes of Telomere Shortening. Annu Rev 
Genomics Hum Genet. 2009; 10: 45‐61. 
30. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green 
DK,  Allshire  RC.  Telomere  reduction  in  human  colorectal 
carcinoma and with ageing. Nature. 1990; 346: 866‐868. 
31. Vaziri H, Schachter F, Uchida I, Wei L, Zhu X, Effros R et al. 
Loss  of  telomeric  DNA  during  aging  of  normal  and  trisomy  21 
human lymphocytes. Am J Hum Genet. 1993; 52: 661‐667. 
32. Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, 
Futcher AB et al. Telomere length predicts replicative capacity of 
human  fibroblasts.  Proc  Natl  Acad  Sci  USA.  1992;  89:  10114‐
10118. 
33. Thibeault SL, Glade RS, Li W. Comparison of telomere length 
of  vocal  folds  with  different  tissues:  a  physiological 
measurement of vocal senescence. J Voice. 2006; 20: 165‐170. 
34.  Nakamura  K,  Izumiyama‐Shimomura  N,  Sawabe  M,  Arai  T, 
Aoyagi  Y,  Fujiwara  M  et  al.  Comparative  analysis  of  telomere 
lengths  and  erosion  with  age  in  human  epidermis  and  lingual 
epithelium. J Invest Dermatol. 2002; 119: 1014‐1019. 
35. Alter BP, Giri N, Savage SA, Peters J, Loud JT, Leathwood L et 
al.  Malignancies  and  survival  patterns  in  the  National  Cancer 
Institute inherited bone marrow failure syndromes cohort study. 
Br J Hemat. 2010; 150: 179‐88. 
36.  Cawthon  RM.  Telomere  length  measurement  by  a  novel 
monochrome multiplex quantitative PCR method. Nucleic Acids 
Res. 2009; 37: e21. 
 
 
www.impactaging.com                   874                                  AGING,  November 2010, Vol.2 No.11
